Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia

Blood

Volumn 113, Issue 20, 2009, Pages 4914-4917

  Bellon, Marcia ^a   Lepelletier, Yves ^b   Hermine, Olivier ^b   Nicot, Christophe ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; T CELL LEUKEMIA; UPREGULATION; BIOLOGICAL MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; PHYSIOLOGY;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIESIS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNITY, INNATE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICRORNAS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 66549107815     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-11-189845     Document Type: Article

References (25)

1. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-866.
2. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838. (Pubitemid 40839735)
3. Kluiver J, Kroesen BJ, Poppema S, van den BA. The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia. 2006;20:1931-1936.
4. García P, Frampton J. Hematopoietic lineage commitment: miRNAs add specificity to a widely expressed transcription factor. Dev Cell. 2008;14:815-816. (Pubitemid 351757207)
5. Garzon R, Croce CM. MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol. 2008;15:352-358.
6. Chen CZ, Lodish HF. MicroRNAs as regulators of mammalian hematopoiesis. Semin Immunol. 2005;17:155-165.
7. Feuer G, Fraser JK, Zack JA et al. Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo. J Virol. 1996;70:4038-4044. (Pubitemid 26157381)
8. Tripp A, Banerjee P, Sieburg M, et al. Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression. J Virol. 2005;79:14069-14078. (Pubitemid 41552704)
9. Nimer SD, Gasson JC, Hu K et al. Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene. 1989;4:671-676. (Pubitemid 19150646)
10. Tokioka T, Shimamoto Y, Motoyoshi K, Yamaguchi M. Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia/lymphoma. Haematologia (Budap). 1994;26:1-269.
11. Datta A, Bellon M, Sinha-Datta U, et al. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood. 2006;108:1021-1029. (Pubitemid 44154640)
12. Huntly BJ, Gilliland DG. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer. 2005;5:311-321. (Pubitemid 40488636)
13. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83-86. (Pubitemid 38055775)
14. Neilson JR, Zheng GX, Burge CB, Sharp PA. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 2007;21:578-589.
15. Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147-161. (Pubitemid 46507589)
16. Fazi F, Rosa A, Fatica A et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005;123:819-831. (Pubitemid 41721029)
17. Xiao C, Calado DP, Galler G, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007;131:146-159. (Pubitemid 47498525)
18. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103:12481-12486. (Pubitemid 44267285)
19. Zhou X, Jeker LT, Fife BT, et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med. 2008;205:1983-1991.
20. Yamano Y, Takenouchi N, Li HC, et al. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest. 2005;115:1361-1368. (Pubitemid 40629056)
21. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9:839-845. (Pubitemid 352038302)
22. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A. 2006;103:7024-7029.
23. Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med. 2008;14:429-436.
24. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316:608-611. (Pubitemid 46683148)
25. Gabet AS, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene. 2000;19:4954-4960. (Pubitemid 30808360)